Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR)

27 filings reported holding MRKR - Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q1 2024.
Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1.91M shares of 16.9M outstanding shares and own 11.33% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (1.07M shares), Aisling Capital Management LP (314K shares), VANGUARD GROUP INC (233K shares), GEODE CAPITAL MANAGEMENT, LLC (67.1K shares), WEDBUSH SECURITIES INC (45.5K shares), RENAISSANCE TECHNOLOGIES LLC (37.3K shares), NORTHERN TRUST CORP (34.8K shares), DIMENSIONAL FUND ADVISORS LP (20.3K shares), STATE STREET CORP (19.7K shares), and Creative Planning (17.3K shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.